Thymosin alpha-1
Thymalfasin — N-Terminally Acetylated 28-Residue Thymic Peptide (Prothymosin α Fragment)
Thymosin Alpha-1 (Tα1; thymalfasin) is a 28-amino-acid N-terminally acetylated polypeptide originally isolated from bovine thymic fraction 5. N-terminal acetylation is critical for biological activity and metabolic stability. Research has characterised Tα1-associated activation of TLR9, TLR2, and TLR4 innate immune signalling via MyD88/NF-κB and TRIF-dependent cascades, dendritic cell maturation, MHC class II upregulation, T-lymphocyte differentiation, CD4⁺/CD8⁺ subset modulation, NK cell cytolytic enhancement, and thymic epithelial gene expression profiling in immune-oncology and vaccine adjuvant research models.
| PROPERTIES | |
|---|---|
| Molecular Formula | C129H215N33O55 |
| Molecular Weight (g/mol) | 3108.3 |
| Monoisotopic Mass (Da) | 3106.5041 |
| Topological Polar Surface Area (Ų) | 1460 |
| Complexity | 7190 |
| XLogP (octanol-water partition) | -24 |
| Heavy Atom Count | 217 |
| H-Bond Donor Count | 49 |
| H-Bond Acceptor Count | 59 |
| Rotatable Bond Count | 111 |
| InChIKey | NZVYCXVTEHPMHE-ZSUJOUNUSA-N |
| PubChem CID | 16130571 |
All values above are taken from PubChem CID 16130571 and can be checked against that record.
2D Structure
| CHEMICAL IDENTIFIERS | |
|---|---|
| CAS Number | 62304-98-7 |
| PubChem CID | 16130571 |
| IUPAC Name | (4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S,3R)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]propanoyl]amino]propanoyl]amino]-3-methylbutanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]-6-aminohexanoyl]amino]-3-carboxypropanoyl]amino]-4-methylpentanoyl]amino]-6-aminohexanoyl]amino]-4-carboxybutanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-4-carboxybutanoyl]amino]-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]propanoyl]amino]-5-[[(1S)-3-amino-1-carboxy-3-oxopropyl]amino]-5-oxopentanoic acid |
| InChIKey | NZVYCXVTEHPMHE-ZSUJOUNUSA-N |
| InChI | InChI=1S/C129H215N33O55/c1-18-59(10)98(159-114(201)76(36-42-91(181)182)146-120(207)83(53-164)154-121(208)84(54-165)155-127(214)99(63(14)166)160-118(205)80(51-94(187)188)152-123(210)95(56(4)5)156-104(191)62(13)135-102(189)60(11)137-115(202)78(49-92(183)184)151-119(206)82(52-163)138-66(17)169)125(212)161-101(65(16)168)128(215)162-100(64(15)167)126(213)147-70(30-22-26-46-133)109(196)150-79(50-93(185)186)117(204)149-77(47-55(2)3)116(203)142-69(29-21-25-45-132)108(195)144-73(33-39-88(175)176)110(197)141-67(27-19-23-43-130)106(193)140-68(28-20-24-44-131)107(194)145-75(35-41-90(179)180)113(200)157-97(58(8)9)124(211)158-96(57(6)7)122(209)148-74(34-40-89(177)178)111(198)143-71(31-37-86(171)172)105(192)136-61(12)103(190)139-72(32-38-87(173)174)112(199)153-81(129(216)217)48-85(134)170/h55-65,67-84,95-101,163-168H,18-54,130-133H2,1-17H3,(H2,134,170)(H,135,189)(H,136,192)(H,137,202)(H,138,169)(H,139,190)(H,140,193)(H,141,197)(H,142,203)(H,143,198)(H,144,195)(H,145,194)(H,146,207)(H,147,213)(H,148,209)(H,149,204)(H,150,196)(H,151,206)(H,152,210)(H,153,199)(H,154,208)(H,155,214)(H,156,191)(H,157,200)(H,158,211)(H,159,201)(H,160,205)(H,161,212)(H,162,215)(H,171,172)(H,173,174)(H,175,176)(H,177,178)(H,179,180)(H,181,182)(H,183,184)(H,185,186)(H,187,188)(H,216,217)/t59-,60-,61-,62-,63+,64+,65+,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,95-,96-,97-,98-,99-,100-,101-/m0/s1 |
| SMILES | CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)C |
Identifiers retrieved from PubChem CID 16130571.
HPLC purity report Sample lot
Thymosin alpha-1
- Lot
- P260819-LR502108
- SKU
- GD-TA1
Integration table as reported
| # | Ret. time | Height | Area | Area % | |
|---|---|---|---|---|---|
| 1 | 10.777 | 6523 | 43893 | 0.5104 | |
| 2 | 11.444 | 840896 | 8474136 | 98.55 | |
| 3 | 11.746 | 14237 | 81422 | 0.9469 | |
Retention time in minutes. Height and area are the report’s own values and units. Method wording is normalised for units and spelling; every value is as reported.
Method as reported
| Column | 250 × 4.6 mm, Kromasil-C18-5 µm |
|---|---|
| Mobile phase A | 0.1% TFA in water |
| Mobile phase B | 0.1% TFA in acetonitrile |
| Flow rate | 1.0 mL/min |
| Detection | 220 nm |
| Injection volume | 5 µL |
| Time | A | B |
|---|---|---|
| 0.1min | 82% | 18% |
| 25.0min | 57% | 43% |
| 25.1min | 0% | 100% |
| 30.0min | Stop | |
Identity verified against PubChem, not a measurement of this lot
- CAS number
- 62304-98-7
- Molecular formula
- C129H215N33O55
- Molecular weight
- 3108.3 g/mol
- Monoisotopic mass
- 3106.5041 Da
- InChIKey
- NZVYCXVTEHPMHE-ZSUJOUNUSA-N
- PubChem CID
- 16130571
Corrections and queries 2 corrected
| Field | On the supplier document | Here | Why |
|---|---|---|---|
| Purity figure | 98.55% | 98.54% | The report's own peak areas give 8,474,136 of 8,599,451, which is 98.5428%. 98.55% is that figure rounded up. We never publish a purity above what the printed areas give, so it is truncated rather than rounded. |
| Compound name | Tymosin alpha1 Acetate | Thymosin alpha-1 | Spelling. The printed name corresponds to thymalfasin, CAS 62304-98-7, and the document also records the acetate salt form. This page is a purity chromatogram: it carries no identity test, so the identity shown below is the PubChem record rather than anything the report measured. |
A measured result is never rewritten. Where a reported figure does not stand up, it is shown as printed and marked as queried.
Sample lot. This is the report supplied with the sample of this compound. A production lot ships with its own report, published here in the same form and indexed by its own lot number.
Every analytical figure above is transcribed from the supplier’s report for lot P260819-LR502108. Identity is the PubChem record, which can be checked independently. Purity is the main peak’s share of integrated peak area at the detection wavelength, so it measures related impurities. Water, salts and counter-ions are not part of it. These are the supplier’s release documents, not independent third-party tests.
This product is sold exclusively for in vitro and laboratory research use. It has not been evaluated by the FDA. Not approved for diagnostic, therapeutic, or veterinary use.
PT-141
Cagrilintide
Semax
Oxytocin